Renaissance Technologies LLC raised its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 85.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 25,900 shares of the company’s stock after buying an additional 11,902 shares during the quarter. Renaissance Technologies LLC owned 0.38% of VanEck Pharmaceutical ETF worth $2,369,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Optimum Investment Advisors acquired a new position in shares of VanEck Pharmaceutical ETF in the second quarter worth $27,000. GPS Wealth Strategies Group LLC acquired a new position in VanEck Pharmaceutical ETF in the 2nd quarter worth about $42,000. CWM LLC acquired a new position in VanEck Pharmaceutical ETF in the 2nd quarter worth about $55,000. International Assets Investment Management LLC purchased a new stake in shares of VanEck Pharmaceutical ETF during the 2nd quarter worth about $86,000. Finally, Comerica Bank lifted its holdings in shares of VanEck Pharmaceutical ETF by 39.4% during the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock valued at $121,000 after buying an additional 378 shares during the last quarter.
VanEck Pharmaceutical ETF Stock Performance
NASDAQ:PPH opened at $94.54 on Wednesday. The company has a market capitalization of $717.56 million, a P/E ratio of 21.04 and a beta of 0.72. The stock’s 50 day moving average price is $95.91 and its 200 day moving average price is $91.99. VanEck Pharmaceutical ETF has a 52 week low of $74.05 and a 52 week high of $99.51.
About VanEck Pharmaceutical ETF
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Featured Articles
- Five stocks we like better than VanEck Pharmaceutical ETF
- How to Calculate Inflation Rate
- Why Lennar Stock Could Be the Best Play in the Housing Market
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Choose Top Rated Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
